Lydia Denworth is a New York-based science writer and author of I Can Hear You Whisper: An Intimate Journey through the Science of Sound and Language.
Lydia Denworth
Contributing writer
The Transmitter
From this contributor
The last two-author neuroscience paper?
Author lists on papers have ballooned, and it’s getting hard to discern contribution.
The promise of telehealth in autism diagnoses
The COVID-19 pandemic forced a reckoning, in which autism clinicians had to redefine best practices and expand how children are evaluated. The remote assessments they developed may help solve a persistent problem: the long wait families endure to get a diagnosis in the United States.
The promise of telehealth in autism diagnoses
By
Lydia Denworth
15 February 2023 | 22 min read
The most personalized medicine: Studying your own child’s rare condition
A handful of scientists are committed to advancing research on the autism-related genetic conditions their own children have.
The most personalized medicine: Studying your own child’s rare condition
By
Lydia Denworth
7 July 2022 | 15 min read
Owen’s odyssey: A year and a half after an autism diagnosis
This is part 2 of Owen’s story. It tracks his early progress in treatment for autism. Part 1 described his difficult path to a diagnosis.
Owen’s odyssey: A year and a half after an autism diagnosis
By
Lydia Denworth
25 November 2020 | 16 min read
A quest for Quincy: Gene therapies come of age for some forms of autism
A gene therapy for Angelman syndrome stands at the forefront of efforts to treat autism-linked conditions that stem from single genes.
A quest for Quincy: Gene therapies come of age for some forms of autism
By
Lydia Denworth, Brendan Borrell
14 October 2020 | 24 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read